ArticleSubstance abuse treatment, prevention, and policy2025
Initial stakeholder perceptions around opioid settlement funds in Pennsylvania.
Article in Substance abuse treatment, prevention, and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides. Beginning in the early 2000s, local and state governments filed a series of lawsuits against opioid manufacturers and distributors. The lawsuits held that manufacturers and distributors knew about the potential addictive nature of these painkillers and withheld this information from providers, leading to overprescription and overdose. The current settlement funds allotted to Pennsylvania amount to approximately 2 billion USD, can be spent over the next 18 years, and are distributed at the county level. This paper investigates the early perceptions of local government officials and substance use service providers in Pennsylvania regarding the rollout of settlement funds and their decisions about how to use them.
methodsThis paper draws on 66 semi-structured interviews and 6 focus groups conducted in 2023 across six Pennsylvania counties. Interviews were audio-recorded, transcribed and inductively coded using NVivo software.
resultsFindings reveal an initial sense of confusion among participants about navigating the funding process, exacerbated by unclear guidelines and insufficient support from state-level officials. Despite these challenges, participants express optimism about the potential for innovative, locally focused projects to effectively address the impacts of the epidemic. Emphasizing the importance of community involvement and transparency, the study highlights a collective commitment to ensuring that funds reach those most affected by the crisis. Yet still, some participants recognized the limits of the settlement funds in addressing the deep trauma that their communities have experienced.
conclusionsThe recommendations underscore the necessity for better systems to outline funding processes, promote best practices, and enhance inter-county collaboration. This research contributes valuable insights into the decision-making dynamics surrounding opioid settlement funds and lays the groundwork for future investigations into their long-term impacts and efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.